scispace - formally typeset
T

Tomasz Huzarski

Researcher at Pomeranian Medical University

Publications -  237
Citations -  12429

Tomasz Huzarski is an academic researcher from Pomeranian Medical University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 51, co-authored 218 publications receiving 10147 citations. Previous affiliations of Tomasz Huzarski include University of Zielona Góra.

Papers
More filters
Journal ArticleDOI

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

Eric Pujade-Lauraine, +110 more
- 01 Sep 2017 - 
TL;DR: Olaparib tablet maintenance treatment provided a significant progression-free survival improvement with no detrimental effect on quality of life in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation.
Journal ArticleDOI

Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer

TL;DR: In this paper, a poly(adenosine diphosphate-ribose) polymerase inhibitor was proposed to target cancers with defects in homologous recombination repair by synthetic lethality.
Journal ArticleDOI

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

Fergus J. Couch, +261 more
- 27 Mar 2013 - 
TL;DR: It is estimated that the breast cancer lifetime risks for the5% of BRCA1 carriers at lowest risk are 28%–50% compared to 81%–100% for the 5% at highest risk, and the ovarian cancer lifetime risk is 63% or higher, based on the known cancer risk-modifying loci.